Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
ANGO: Stock Quote & Summary Data
0.19%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 155,050 |
| Previous Close | $ 15.75 |
| 52 Wk High / Low | $ 16 / $ 9.12 |
| Shares Outstanding | 24,501,000 |
| Market Value | $ 385,155,720 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.54 |
| NASDAQ Official Open Price: | $ 15.61 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 15.72 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About ANGO?
Ask your question about about AngioDynamics, Inc. (ANGO) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a provider of innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease, or PVD, and local oncology therapy options for treating cancer, including radiofrequency ablation, or RFA, and systems and embolization products for treating cancerous tumors. We design, develop, manufacture and market a broad line of therapeutic and diagnostic devices that enable interventional physicians (interventional radiologists, vascular surgeons, surgical oncologists and others) to treat PVD, tumors, and other non-coronary diseases. Unlike several of our competitors that focus on the treatment of coronary diseases, we believe that we are the only company whose primary focus is to offer a comprehensive product line for the interventional treatment of these diseases. We have been in business since 1988. Our corporate headquarters is located at 603 Queensbury Avenue, Queensbury, New York 12804. ... More ...
Links to all AngioDynamics, Inc. (ANGO) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for ANGO |
||
|
AngioDynamics Appoints Stephen McGill As SVP And General Manager, International, Effective November 1 - Quick Facts - RTT News 10/27/2009 6:44AM |
||
|
AngioDynamics Appoints Stephen McGill as Senior Vice President and General Manager, International - Business Wire 10/27/2009 6:30AM |
||
|
AngioDynamics Q1 Profit Declines, Yet Beats Estimates; Tightens FY10 Forecast - Update - RTT News 10/06/2009 5:53PM |
||
|
AngioDynamics Q1 Profit Edges Down; Tightens FY10 Outlook - Quick Facts - RTT News 10/06/2009 4:17PM |
||
|
AngioDynamics Reports Fiscal First Quarter 2010 Financial Results - Business Wire 10/06/2009 4:02PM |
||
|
AngioDynamics Q1 10 Earnings Conference Call At 4:30 PM - RTT News 10/06/2009 2:25PM |
||
|
Beacon Equity Issues Trading Outlook for BSD Medical Corp. - GlobeNewswire 09/23/2009 6:50AM |
